Cargando…

Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort

INTRODUCTION: The objective of the present study was to examine the association of baseline demographic and clinical characteristics with sequentially obtained measurements of forced vital capacity (FVC), expressed as a percentage of the predicted value, and to identify predictors of the decline rat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Assassi, Shervin, Sharif, Roozbeh, Lasky, Robert E, McNearney, Terry A, Estrada-Y-Martin, Rosa M, Draeger, Hilda, Nair, Deepthi K, Fritzler, Marvin J, Reveille, John D, Arnett, Frank C, Mayes, Maureen D
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990992/ https://www.ncbi.nlm.nih.gov/pubmed/20813056 http://dx.doi.org/10.1186/ar3125

Ejemplares similares

Predictors of Fatigue Severity in Early Systemic Sclerosis: A Prospective Longitudinal Study of the GENISOS Cohort
por: Assassi, Shervin, et al.
Publicado: (2011)

Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis
por: Gourh, Pravitt, et al.
Publicado: (2010)

Right Bundle Branch Block: A Predictor of Mortality in Early Systemic Sclerosis
por: Draeger, Hilda T., et al.
Publicado: (2013)

Correction: Right Bundle Branch Block: A Predictor of Mortality in Early Systemic Sclerosis
por: Draeger, Hilda T., et al.
Publicado: (2014)

Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls
por: Arnett, Frank C, et al.
Publicado: (2010)

The Effect of Anti‐Scl‐70 Antibody Determination Method on Its Predictive Significance for Interstitial Lung Disease Progression in Systemic Sclerosis
por: Jandali, Bochra, et al.
Publicado: (2022)

Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations
por: Gourh, Pravitt, et al.
Publicado: (2009)

Anorectal Motility and Sensation Abnormalities and Its Correlation with Anorectal Symptoms in Patients with Systemic Sclerosis: A Preliminary Study
por: Sallam, Hanaa S., et al.
Publicado: (2011)

Decreased catalytic function with altered sumoylation of DNA topoisomerase I in the nuclei of scleroderma fibroblasts
por: Zhou, Xiaodong, et al.
Publicado: (2011)

Pluripotential GluN1 (NMDA NR1): Functional Significance in Cellular Nuclei in Pain/Nociception
por: McNearney, Terry A., et al.
Publicado: (2023)

Osteopontin in Systemic Sclerosis and its Role in Dermal Fibrosis
por: Wu, Minghua, et al.
Publicado: (2012)

Enrichment Strategy for Systemic Sclerosis Clinical Trials Targeting Skin Fibrosis: A Prospective, Multiethnic Cohort Study
por: Mihai, Carina, et al.
Publicado: (2020)

Genetics of scleroderma: implications for personalized medicine?
por: Assassi, Shervin, et al.
Publicado: (2013)

Impact of central and peripheral TRPV1 and ROS levels on proinflammatory mediators and nociceptive behavior
por: Westlund, Karin N, et al.
Publicado: (2010)

Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease
por: Volkmann, Elizabeth R., et al.
Publicado: (2016)

Cannabinoid receptor 2 agonist attenuates pain related behavior in rats with chronic alcohol/high fat diet induced pancreatitis
por: Zhang, Liping, et al.
Publicado: (2014)

Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?
por: Farutin, Victor, et al.
Publicado: (2021)

Understanding diagnostic pathways in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: A retrospective cohort study
por: Assassi, Shervin, et al.
Publicado: (2022)

Pancreas Cancer‐Associated Pain Management
por: Coveler, Andrew L., et al.
Publicado: (2021)

Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations
por: Hoa, S., et al.
Publicado: (2016)

The Role of Type 1 Interferon in Systemic Sclerosis
por: Wu, Minghua, et al.
Publicado: (2013)

Tumor necrosis factor-alpha (TNF-α) enhances functional thermal and chemical responses of TRP cation channels in human synoviocytes
por: Kochukov, Mikhail Y, et al.
Publicado: (2009)

Peripheral blood gene expression profiling shows predictive significance for response to mycophenolate in systemic sclerosis-related interstitial lung disease
por: Assassi, Shervin, et al.
Publicado: (2022)

Enkephalin-encoding herpes simplex virus-1 decreases inflammation and hotplate sensitivity in a chronic pancreatitis model
por: Yang, Hong, et al.
Publicado: (2008)

Quantitative proteomic screening uncovers candidate diagnostic and monitoring serum biomarkers of ankylosing spondylitis
por: Hwang, Mark, et al.
Publicado: (2023)

Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patients
por: Wu, Minghua, et al.
Publicado: (2016)

Predictors of progression in systemic sclerosis patients with interstitial lung disease
por: Distler, Oliver, et al.
Publicado: (2020)

Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes
por: Hanson, Aimee L., et al.
Publicado: (2022)

Tyrosine Kinase Inhibitors Reduce NMDA NR1 Subunit Expression, Nuclear Translocation, and Behavioral Pain Measures in Experimental Arthritis
por: Westlund, Karin N., et al.
Publicado: (2020)

Association of the HLA-DRB1 with Scleroderma in Chinese Population
por: He, Dongyi, et al.
Publicado: (2014)

Circulating cytokine levels in systemic sclerosis related interstitial lung disease and idiopathic pulmonary fibrosis
por: Zheng, Boyang, et al.
Publicado: (2023)

LY3127760, a Selective Prostaglandin E4 (EP4) Receptor Antagonist, and Celecoxib: A Comparison of Pharmacological Profiles
por: Jin, Yan, et al.
Publicado: (2017)

Profiling of HLA-B Alleles for Association Studies with Ankylosing Spondylitis in the Chinese Population
por: Yi, Lin, et al.
Publicado: (2013)

Effect of Nintedanib on Progression of Systemic Sclerosis‐Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial
por: Assassi, Shervin, et al.
Publicado: (2022)

Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial
por: Seibold, James R, et al.
Publicado: (2020)

Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression
por: Khanna, Dinesh, et al.
Publicado: (2023)

Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need
por: Herrick, Ariane L., et al.
Publicado: (2022)

Interstitial fibrosis and growth factors.
por: Lasky, J A, et al.
Publicado: (2000)

Autoantibodies in Systemic Sclerosis: Unanswered Questions
por: Kayser, Cristiane, et al.
Publicado: (2015)

Psychological correlates of self-reported functional limitation in patients with ankylosing spondylitis
por: Brionez, Tamar F, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_r55jjk5vfq8gt7ces8n42fj0ib